Basit öğe kaydını göster

dc.contributor.authorBattal, Muharrem
dc.contributor.authorGürbulak, Bünyamin
dc.contributor.authorBostancı, Özgür
dc.contributor.authorYılmaz, Müveddet Banu
dc.contributor.authorÖzdenkaya, Yaşar
dc.contributor.authorKaratepe, Oǧuzhan
dc.date.accessioned10.07.201910:49:13
dc.date.accessioned2019-07-10T19:36:34Z
dc.date.available10.07.201910:49:14
dc.date.available2019-07-10T19:36:34Z
dc.date.issued2014
dc.identifier.citationBattal, M., Gürbulak, B., Bostancı, Ö., Yılmaz, M. B., Özdenkaya, Y. ve Karatepe, O. (2014). Cholangiocarcinoma presenting with hypercalcemia and thrombocytopenia. Case Reports in Medicine, 2014. https://dx.doi.org/10.1155/2014/246817en_US
dc.identifier.issn1687-9627
dc.identifier.urihttps://hdl.handle.net/20.500.12511/1201
dc.identifier.urihttps://dx.doi.org/10.1155/2014/246817
dc.description.abstractMalignant hypercalcemia and thrombocytopenia may result from bone metastasis of cholangiocarcinoma (CC). Our case was 53-year-old man admitted to emergency department with symptoms of anorexia, weight loss, nausea, vomiting, and general fatigue in February 2012. His laboratory findings showed hypercalcemia and thrombocytopenia. CT showed a large multinodular mass in the right lobe and, extending through left lobe of the liver. We considered the diagnosis of hypercalcemia of malignancy with elevated calcium levels and suppressed PTH level with the existence of skeletal bone metastasis and the absence of parathyroid gland pathology. Treatment of hypercalcemia with IV saline, furosemide, and calcitonin improved the patient symptoms. After the 8th day of admission, calcium level, thrombocytopenia, and other symptoms were normalized. Patient was sustained surgically inoperable and transferred to medical oncology department for the purpose of palliative chemotherapy and intended radiotherapy for bone metastasis. Hypercalcemia relapsed 4 weeks after discharge and patient died at the 5th month after admission due to disseminated metastasis. We should be aware of CC with symptomatic hypercalcemia and rarely low platelet count. The correction of hypercalcemia provides symptomatic relief and stability of patients.en_US
dc.language.isoengen_US
dc.publisherHindawi Publishing Corporationen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.rightsAttribution 3.0 Unported*
dc.rights.urihttps://creativecommons.org/licenses/by/3.0/*
dc.subjectHypercalcemiaen_US
dc.subjectThrombocytopeniaen_US
dc.subjectCholangiocarcinoma (CC)en_US
dc.titleCholangiocarcinoma presenting with hypercalcemia and thrombocytopeniaen_US
dc.typearticleen_US
dc.relation.ispartofCase Reports in Medicineen_US
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü, Genel Cerrahi Ana Bilim Dalıen_US
dc.authorid0000-0003-0428-2511en_US
dc.identifier.volume2014en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.identifier.doi10.1155/2014/246817en_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster

info:eu-repo/semantics/openAccess
Aksi belirtilmediği sürece bu öğenin lisansı: info:eu-repo/semantics/openAccess